Healthcare - Biotechnology - NASDAQ - US
$ 24.05
-8.59 %
$ 1.99 B
Market Cap
-15.22
P/E
Price Target
Average
128.69%
Revenue Forecast
Estimate
--10.14%
EBIT
Estimate
--5.67%
Net Income
Estimate
--15.06%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Beam Therapeutics Inc.
Wall Street analysts predict an average 1-year price target for BEAM of $55 , with forecasts ranging from a low of $39 to a high of $69 .
BEAM Lowest Price Target
Wall Street Target
39 USD
62.16%
BEAM Average Price Target
Wall Street Target
55 USD
128.69%
BEAM Highest Price Target
Wall Street Target
69 USD
186.90%
REVENUE FORECAST
Revenue Forecast Chart BEAM
EBIT FORECAST
EBIT Forecast Chart BEAM
NET INCOME FORECAST
Net Income Chart BEAM